Archives of General Psychiatry · 2008 · 315 citations · 49 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyGlutamatergic NeurochemistryGlutamatergic PharmacologyNeurochemical PharmacologyPlacebo EffectBlood Oxygenation Level-dependent ContrastGlutamate NeurotransmissionKetamine PharmacologyKetamine TreatmentLamotrigine TreatmentN-methyl-d-aspartate Receptor AntagonismN-methyl-d-aspartate Receptor InhibitionSubjective Drug Effects
CONTEXT: Ketamine evokes psychosislike symptoms, and its primary action is to impair N-methyl-D-aspartate glutamate receptor neurotransmission, but it also induces secondary increases in glutamate release. OBJECTIVES: To identify the sites of action of ketamine in inducing symptoms and to determine the role of increased glutamate release using the glutamate release inhibitor lamotrigine. DESIGN: Two experiments with different participants were performed using a double-blind, placebo-controlled, randomized, crossover, counterbalanced-order design. In the first experiment, the effect of intravenous ketamine hydrochloride on regional blood oxygenation level-dependent (BOLD) signal and correlated symptoms was compared with intravenous saline placebo. In the second experiment, pretreatment with lamotrigine was compared with placebo to identify which effects of ketamine are mediated by increased glutamate release. SETTING: Wellcome Trust Clinical Research Facility, Manchester, England. PARTICIPANTS: Thirty-three healthy, right-handed men were recruited by advertisements. INTERVENTIONS: In experiment 1, participants were given intravenous ketamine (1-minute bolus of 0.26 mg/kg, followed by a maintenance infusion of 0.25 mg/kg/h for the remainder of the session) or placebo (0.9% saline solution). In experiment 2, participants were pretreated with 300 mg of lamotrigine or placebo and then were given the same doses of ketamine as in experiment 1. MAIN OUTCOME MEASURES: Regional BOLD signal changes during ketamine or placebo infusion and Brief Psychiatric Rating Scale and Clinician-Administered Dissociative States Scale scores. RESULTS: Ketamine induced a rapid, focal, and unexpected decrease in ventromedial frontal cortex, including orbitofrontal cortex and subgenual cingulate, which strongly predicted its dissociative effects and increased activity in mid-posterior cingulate, thalamus, and temporal cortical regions (r = 0.90). Activations correlated with Brief Psychiatric Rating Scale psychosis scores. Lamotrigine pretreatment prevented many of the BOLD signal changes and the symptoms. CONCLUSIONS: These 2 changes may underpin 2 fundamental processes of psychosis: abnormal perceptual experiences and impaired cognitive-emotional evaluation of their significance. The results are compatible with the theory that the neural and subjective effects of ketamine involve increased glutamate release.
49
A default mode of brain function
Marcus E. Raichle, Ann Mary MacLeod, Abraham Z. Snyder et al. · Proceedings of the National Academy of Sciences · 2001 · 12.4K citations
Deep Brain Stimulation for Treatment-Resistant Depression
Helen S. Mayberg, Andrés M. Lozano, Valerie Voon et al. · Neuron · 2005 · 4.1K citations · Full text
Antidepressant effects of ketamine in depressed patients
Robert Berman, Angela Cappiello, Amit Anand et al. · Biological Psychiatry · 2000 · 3.8K citations
Medicine, Pharmacology, Psychiatry +14
Glutamate Receptor Dysfunction and Schizophrenia
John W. Olney · Archives of General Psychiatry · 1995 · 1.7K citations
Medicine, Neuroscience, Psychiatry +17
Acute Effects of Cocaine on Human Brain Activity and Emotion
Randy L. Gollub, Robert M. Weisskoff, David N. Kennedy et al. · Neuron · 1997 · 1.3K citations · Full text
Medicine, Neurobiology, Neuroscience +14